V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310009224 | 310004109 | 1.66 | 77.4 | null | null | 2016-06-18 | LEAM | N | N | 310013974 | LEAM |
| 310009225 | 310009610 | null | null | Palliative (P) | 2017-11-17 | 2018-01-13 | PEMBROLIZUMAB | 2 | N | 310014039 | PEMBROLIZUMAB |
| 310009226 | 310004112 | null | 72 | Palliative (P) | 2018-01-22 | 2018-11-09 | PEMBROLIZUMAB | 2 | N | 310014119 | PEMBROLIZUMAB |
| 310009227 | 310007707 | 1.74 | 73.2 | Palliative (P) | 2015-01-13 | 2015-01-13 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310014178 | CISPLATIN + GEMCITABINE |
| 310009228 | 310004118 | 1.86 | 71.1 | Not known (9) | 2019-02-01 | 2019-02-07 | IVE | 2 | N | 310014179 | IVE |
| 310009229 | 310004120 | 1.69 | null | Curative (C) | 2016-03-26 | 2016-05-17 | LEAM | 02 | N | 310014190 | LEAM |
| 310009230 | 310004122 | 1.83 | 56.2 | Curative (C) | null | 2014-11-15 | GEMCITABINE | N | N | 310014200 | GEMCITABINE |
| 310009231 | 310004124 | 1.18 | 54.8 | Disease modification (D) | 2018-01-10 | 2018-01-26 | CNS LGG 2004 03 cons vinc +cyclo | 02 | N | 310014209 | NOT MATCHED |
| 310009232 | 310004125 | 1.78 | 85 | Curative (C) | 2017-05-23 | 2017-12-23 | GEMCITABINE | 02 | null | 310014225 | GEMCITABINE |
| 310009233 | 310004130 | 1.5 | null | null | 2016-07-26 | 2016-07-29 | GEMCITABINE | 2 | N | 310014287 | GEMCITABINE |
| 310009234 | 310007717 | 1.66 | 86.2 | Curative (C) | 2014-01-31 | 2014-02-19 | Mini BEAM | N | N | 310014297 | BEAM |
| 310009235 | 310009612 | 1.8 | 94 | Palliative (P) | 2016-05-12 | 2016-05-17 | Mini BEAM | N | N | 310014324 | BEAM |
| 310009236 | 310004134 | 1.57 | 68.15 | Palliative (P) | 2016-05-17 | 2016-05-17 | Brentuximab | 02 | N | 310014350 | BRENTUXIMAB |
| 310009237 | 310004135 | 1.88 | 89 | Curative (C) | 2015-07-28 | 2015-08-06 | BEAM | 2 | N | 310014361 | BEAM |
| 310009238 | 310004137 | 1.74 | 91.2 | Palliative (P) | 2016-07-15 | 2016-07-15 | BEAM | null | null | 310014414 | BEAM |
| 310009239 | 310004138 | 1.79 | 76 | Palliative (P) | 2014-11-05 | 2014-11-26 | GEM-P | N | N | 310014426 | GEMCITABINE + PACLITAXEL |
| 310009241 | 310004143 | 1.87 | 79.9 | Palliative (P) | 2016-03-06 | 2016-03-27 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310014454 | CISPLATIN + GEMCITABINE |
| 310009242 | 310004145 | 1.57 | null | Disease modification (D) | 2015-10-22 | 2015-10-28 | Brentuximab Vedotin | N | N | 310014474 | BRENTUXIMAB |
| 310009243 | 310004145 | null | 92 | null | 2016-12-19 | 2016-12-19 | IVE | 2 | N | 310014474 | IVE |
| 310009244 | 310004148 | 1.65 | 61.4 | Curative (C) | null | 2015-11-29 | NB HRNBL-1 BUMEL MAT | N | N | 310014483 | NOT MATCHED |
| 310009245 | 310007725 | 1.7 | 89.6 | Palliative (P) | null | 2015-08-05 | Carboplatin + Liposomal Doxorubicin | N | N | 310014489 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009246 | 310004158 | 1.66 | 60.85 | Palliative (P) | 2016-10-18 | 2016-10-29 | CISPLATIN + GEMCITABINE | 2 | N | 310014582 | CISPLATIN + GEMCITABINE |
| 310009247 | 310009619 | null | 13.2 | Disease modification (D) | 2018-03-27 | 2018-04-08 | NB HRNBL-1 BUMEL MAT | N | N | 310014597 | NOT MATCHED |
| 310009248 | 310007731 | 1.69 | 74 | null | 2013-03-27 | 2013-04-04 | Brentuximab | N | N | 310014640 | BRENTUXIMAB |
| 310009249 | 310004163 | null | 99.6 | Curative (C) | 2017-09-16 | 2017-09-16 | Brentuximab | 2 | N | 310014659 | BRENTUXIMAB |
| 310009251 | 310009623 | 1.55 | 63.2 | Palliative (P) | 2017-10-31 | 2017-11-08 | CARBOPLATIN + LIPOSOMAL DOX | 2 | Y | 310014692 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009252 | 310009623 | 1.73 | 75 | Curative (C) | 2014-07-25 | 2014-07-26 | IVE | N | N | 310014692 | IVE |
| 310009253 | 310009623 | 1.63 | 80 | Curative (C) | 2016-04-30 | 2016-05-01 | LEAM | 02 | N | 310014692 | LEAM |
| 310009254 | 310004167 | null | 91 | Palliative (P) | 2019-01-15 | 2019-03-02 | PEMBROLIZUMAB | Y | N | 310014723 | PEMBROLIZUMAB |
| 310009255 | 310004170 | null | 98 | Curative (C) | 2016-07-11 | 2016-07-27 | IVE | 02 | N | 310014746 | IVE |
| 310009256 | 310004170 | 1.82 | 16.8 | Curative (C) | 2013-09-14 | 2014-01-26 | IVE | N | N | 310014746 | IVE |
| 310009257 | 310004174 | 1.77 | 54.8 | Curative (C) | 2016-02-22 | 2016-02-24 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310014843 | CISPLATIN + GEMCITABINE |
| 310009259 | 310004177 | 1.72 | 68 | Curative (C) | 2017-05-15 | 2017-05-15 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 310014855 | CISPLATIN + GEMCITABINE |
| 310009260 | 310004177 | 1.62 | 63 | Palliative (P) | 2014-09-02 | 2014-09-20 | Gemcitabine weekly | 02 | N | 310014855 | GEMCITABINE |
| 310009261 | 310004181 | 1.72 | 49.7 | Palliative (P) | 2016-03-19 | 2016-03-31 | BEAM | N | N | 310014873 | BEAM |
| 310009262 | 310004184 | 1.5 | 102 | Palliative (P) | 2016-06-19 | 2016-06-25 | BEAM | N | N | 310014908 | BEAM |
| 310009263 | 310004185 | 1.55 | null | Palliative (P) | 2016-09-08 | 2016-09-08 | Carboplatin + Liposomal Doxorubicin | 2 | null | 310014958 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009264 | 310004188 | 1.66 | 59.2 | Palliative (P) | 2016-01-24 | 2016-01-24 | CYTARABINE + ETOPOSIDE + MELPHALAN EAM (no cytarabine) autologous translant | 02 | N | 310014959 | NOT MATCHED |
| 310009265 | 310004189 | 1.57 | 50.8 | Curative (C) | 2017-03-07 | 2017-03-07 | Brentuximab | 02 | N | 310014972 | BRENTUXIMAB |
| 310009266 | 310004195 | 1.61 | 69.7 | Palliative (P) | 2016-09-06 | 2016-12-31 | Carboplatin + Liposomal Doxorubicin | N | N | 310014991 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009267 | 310004201 | null | 70.6 | Palliative (P) | null | 2016-05-06 | Brentuximab Vedotin | 02 | N | 310015002 | BRENTUXIMAB |
| 310009268 | 310007750 | 1.55 | 74 | Palliative (P) | 2017-12-28 | 2018-01-02 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310015008 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009269 | 310004204 | null | 69.4 | Palliative (P) | 2012-09-01 | 2013-04-06 | PEMBROLIZUMAB | 02 | N | 310015039 | PEMBROLIZUMAB |
| 310009270 | 310004207 | 1.66 | 80.75 | Curative (C) | 2018-12-02 | 2018-12-09 | GEM-P | 2 | N | 310015043 | GEMCITABINE + PACLITAXEL |
| 310009271 | 310004209 | 1.67 | 84.1 | Palliative (P) | 2014-05-30 | 2014-06-04 | GEM-P | 2 | N | 310015060 | GEMCITABINE + PACLITAXEL |
| 310009272 | 310004213 | 1.7 | 101 | Palliative (P) | 2013-01-14 | 2013-05-07 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310015077 | CISPLATIN + GEMCITABINE |
| 310009274 | 310004215 | 1.85 | 56.2 | Palliative (P) | 2016-03-07 | 2016-03-26 | Crisantaspase + METHOTREXATE | N | N | 310015114 | NOT MATCHED |
| 310009276 | 310007762 | 1.78 | null | Palliative (P) | 2015-10-06 | 2015-10-20 | Brentuximab | 02 | N | 310015269 | BRENTUXIMAB |
| 310009277 | 310004223 | 1.81 | 80.1 | Curative (C) | 2018-05-19 | 2018-05-19 | BEAM | 02 | N | 310015279 | BEAM |
| 310009278 | 310004223 | 1.63 | 66.2 | Curative (C) | 2018-06-11 | 2018-06-12 | IVE | 02 | N | 310015279 | IVE |